Cargando…
Considerations for the Terminal Sterilization of Oligonucleotide Drug Products
A primary function of the parenteral drug product manufacturing process is to ensure sterility of the final product. The two most common methods for sterilizing parenteral drug products are terminal sterilization (TS), whereby the drug product is sterilized in the final container following filling a...
Autores principales: | DeCollibus, Daniel Paul, Searcy, Justin, Tivesten, Anna, Akhtar, Nadim, Lindenberg, Christian, Abarrou, Nounja, Pradhan, Sujana, Fiandaca, Maggie, Franklin, Jenny, Govindan, Geetha, Liu, Hung-Yi, Royle, David, Soo, Patrick Lim, Storch, Kirsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277985/ https://www.ncbi.nlm.nih.gov/pubmed/36787481 http://dx.doi.org/10.1089/nat.2022.0073 |
Ejemplares similares
-
Technical Considerations for Use of Oligonucleotide Solution API
por: Muslehiddinoglu, Jale, et al.
Publicado: (2020) -
Molecular Mechanisms of Antisense Oligonucleotides
por: Crooke, Stanley T.
Publicado: (2017) -
Perspectives on the Designation of Oligonucleotide Starting Materials
por: Kiesman, William F., et al.
Publicado: (2021) -
Guidelines for Experiments Using Antisense Oligonucleotides and Double-Stranded RNAs
por: Gagnon, Keith T., et al.
Publicado: (2019) -
Considerations of the Japanese Research Working Group for the ICH S6 & Related Issues Regarding Nonclinical Safety Assessments of Oligonucleotide Therapeutics: Comparison with Those of Biopharmaceuticals
por: Hirabayashi, Yoko, et al.
Publicado: (2021)